05/20/2025
5:50 PM | Giordano Christopher Thomas (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
5:54 PM | Rich Stuart (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
4:44 PM | Tenax Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
05/15/2025
7:34 AM | RTW INVESTMENTS, LP (Filed by)
Tenax Therapeutics (Subject)
| Form SCHEDULE 13G | |
05/14/2025
11:50 AM | JANUS HENDERSON GROUP PLC (Filed by)
Tenax Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/25/2025
6:42 AM | Tenax Therapeutics (Filer)
| Form DEF 14A | |
04/25/2025
6:45 AM | Tenax Therapeutics (Filer)
| Form DEFA14A | |
04/25/2025
6:47 AM | Tenax Therapeutics (Filer)
| Form ARS | |
04/23/2025
11:15 PM | Tenax Therapeutics (Filer)
| Form EFFECT | |
04/23/2025
3:10 PM | Tenax Therapeutics (Filer)
| Form 424B3 | |
04/15/2025
4:24 PM | Tenax Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
Get the Latest News and Ratings for TENX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Tenax Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/09/2025
3:06 PM | Tenax Therapeutics (Filer)
| Form PRE 14A | |
04/04/2025
3:53 PM | Dellora Investments LP (Filed by)
Tenax Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
03/12/2025
4:26 PM | Dellora Investments LP (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
4:00 PM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
11:37 AM | JANUS HENDERSON GROUP PLC (Filed by)
Tenax Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/15/2025
3:14 PM | Dellora Investments LP (Filed by)
Tenax Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/10/2025
3:27 PM | Dellora Investments LP (Reporting)
Tenax Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/12/2024
7:02 PM | Giordano Christopher Thomas (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:04 PM | Hunter Robyn (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:07 PM | PROEHL GERALD T (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:09 PM | Rich Stuart (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:49 PM | Almenoff June Sherie (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:54 PM | Davidson Michael H. (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:58 PM | Doogan Declan (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
3:54 PM | MCGAULEY THOMAS (Reporting)
Tenax Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/05/2024
12:47 PM | Dellora Investments LP (Filed by)
Tenax Therapeutics (Subject)
| Form SCHEDULE 13G | |
11/26/2024
3:30 PM | Tenax Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/14/2024
6:14 PM | Lind Global Fund II LP (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
11/14/2024
11:39 AM | JANUS HENDERSON GROUP PLC (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
11:21 AM | CVI Investments, Inc. (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
4:35 PM | Stonepine Capital Management, LLC (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
7:15 AM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
8:32 AM | Adage Capital Management, L.P. (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
10/30/2024
3:32 PM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
7:14 AM | Tenax Therapeutics (Filer)
| Form DEF 14A | |
09/12/2024
11:15 PM | Tenax Therapeutics (Filer)
| Form EFFECT | |
09/12/2024
3:15 PM | Tenax Therapeutics (Filer)
| Form 424B3 | |
09/10/2024
4:19 PM | PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
08/30/2024
3:19 PM | Tenax Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/30/2024
3:20 PM | Tenax Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Recession Fears Mounting? 2 AI Stocks to Watch Now (Ad) 2025 is off to a turbulent start—markets are swinging wildly, inflation pressures remain high, and recession fears are creeping back into headlines.
But even in uncertain times, innovation doesn’t slow down.
In fact, artificial intelligence (AI) is accelerating faster than ever—creating new profit opportunities while the broader market struggles.
Our latest research reveals two AI stocks trading under $15 that could thrive even as volatility grows. These under-the-radar companies are positioned to ride the next wave of AI-driven demand—and they’re still flying below most investors’ radar. 👉[Click here to access your FREE AI stocks report now.] |
08/23/2024
3:31 PM | Tenax Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
08/19/2024
5:48 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
08/15/2024
3:19 PM | Stonepine Capital Management, LLC (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
08/14/2024
5:47 PM | Tenax Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G | |
08/14/2024
2:19 PM | JANUS HENDERSON GROUP PLC (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
08/13/2024
3:45 PM | Tenax Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
7:35 AM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:42 PM | Davidson Michael H. (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
6:43 PM | PROEHL GERALD T (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
6:23 AM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
3:32 PM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy TENX Stock Free TENX Stock Alerts